AMERICAN TECHNOLOGIES GROUP INC
S-3/A, 1999-03-03
MOTOR VEHICLES & MOTOR VEHICLE PARTS & SUPPLIES
Previous: AMERICAN TECHNOLOGIES GROUP INC, 10KSB/A, 1999-03-03
Next: EQUUS II INC, 40-17F2, 1999-03-03



<PAGE>
   

           As filed with the Securities and Exchange Commission on March 3, 1999
                                                      Registration No. 333-68327
    
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549

                                   --------------

                                 Amendment No. 2 to
                                      Form S-3
                               REGISTRATION STATEMENT
                                       Under
                             THE SECURITIES ACT OF 1933

                                   --------------

                         AMERICAN TECHNOLOGIES GROUP, INC.
               (Exact Name of Registrant as Specified in Its Charter)

            Nevada                                     95-4307525
(State or Other Jurisdiction of                    (I.R.S. Employer
 Incorporation or Organization)                   Identification No.)

                             1017 South Mountain Avenue
                             Monrovia, California 91016
                                   (626) 357-5000
    (Address, Including Zip Code, and Telephone Number, Including Area Code, of
                     Registrant's Principal Executive Offices)
                                          
                         American Technologies Group, Inc.
                             1017 South Mountain Avenue
                             Monrovia, California 91016
                                   (626) 357-5000
(Name, Address, and Telephone Number, Including Area Code, of Agent for Service)
                                          
                                     Copies to:
                                 JOHN M. DAB, ESQ.
                                  General Counsel
                         American Technologies Group, Inc.
                             1017 South Mountain Avenue
                             Monrovia, California 91016
                                   (626) 357-5000
                             Telecopy:  (626) 357-4464

     APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon as
practicable after this Registration Statement becomes effective.

     If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [ ]

     If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [X]

     If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [ ]

     If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]  If delivery of the prospectus is expected to be made
pursuant to Rule 434 please check the following box.[ ]

<PAGE>

                          CALCULATION OF REGISTRATION FEE
   
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------
                                                  Proposed         Proposed
                                                   Maximum          Maximum        Amount of
                              Amount to be        Offering         Aggregate      Registration
  Title of Securities to       Registered         Price per         Offering          Fee
      be Registered                               Share (1)        Price (1)
- -----------------------------------------------------------------------------------------------
<S>                          <C>                  <C>           <C>             <C>
   Common Stock, $0.001      2,500,000 shares       $0.65       $  1,625,000    $    451.75 (5)
      par value (2)                             
- -----------------------------------------------------------------------------------------------
   Common Stock, $0.001        440,000 shares       $0.58       $    255,200    $     70.95 (5)
      par value (3)                             
- -----------------------------------------------------------------------------------------------
   Common Stock, $0.001        700,000 shares       $0.51       $    357,500    $     99.25
      par value                                 
- -----------------------------------------------------------------------------------------------
   Common Stock, $0.001        212,000 shares       $0.75       $    159,375    $     44.31 (6)
      par value (4)                             
- -----------------------------------------------------------------------------------------------
   Common Stock, $0.001        620,000 shares       $0.50       $    310,000    $     86.18
      par value (3)                             
- -----------------------------------------------------------------------------------------------
          Total              4,472,500 shares                   $  2,706,575    $    752.44 (7)
- -----------------------------------------------------------------------------------------------
</TABLE>
    

(1)    Estimated solely for the purpose of computing the amount of the 
registration fee pursuant to Rule 457(c).

(2)    Issuable upon the conversion of the 6% Convertible Debentures. This is 
not intended to constitute a prediction as to the number of shares of Common 
Stock into which the Debentures will be converted.  In addition to the shares 
set forth in the table, pursuant to Rule 416 under the Securities Act of 
1933, as amended, this Registration Statement also covers an indeterminate 
number of additional shares of Common Stock as may become issuable as a 
result of stock splits, stock dividends and antidilution provisions.

(3)    Issuable upon the conversion of the 3% Convertible Debentures. This is 
not intended to constitute a prediction as to the number of shares of Common 
Stock into which the Debentures will be converted.  In addition to the shares 
set forth in the table, pursuant to Rule 416 under the Securities Act of 
1933, as amended, this Registration Statement also covers an indeterminate 
number of additional shares of Common Stock as may become issuable as a 
result of stock splits, stock dividends and antidilution provisions.

(4)    Issuable upon exercise of warrants evidencing the right to purchase 
shares  of Common Stock.

(5)    This amount was previously paid.

(6)    $32.84 of this amount was paid with the previous filings of this 
Registration Statement. An additional fee of $11.47 is paid herewith to cover 
an additional 55,000 shares of Common Stock.

   
(7)    $555.54 of this amount was paid with the previous filings of this 
Registration Statement  An additional fee of $196.90 is paid herewith to cover 
an additional 675,000 shares of Common Stock.
    

The registrant hereby amends this registration statement on such date or 
dates as may be necessary to delay its effective date until the registrant 
shall file a further amendment which specifically states that this 
registration statement shall thereafter become effective in accordance with 
section 8(a) of the securities act of 1933 or until the registration 
statement shall become effective on such date as the commission, acting 
pursuant to said section 8(a), may determine.

<PAGE>
   
                          4,472,500 SHARES OF COMMON STOCK

                          AMERICAN TECHNOLOGIES GROUP INC.

       The 4,472,500 shares of common stock being offered by this prospectus 
are being offered by the holders of 700,000 shares of common stock, 
$1,600,000 principal amount of convertible debentures and the holders of 
212,500 warrants to purchase common stock.  See "Selling Securityholders" on 
page 15.

       The selling securityholders may offer these shares from time to time 
in transactions on the OTC Bulletin Board or in privately negotiated 
transactions as described under the "Plan of Distribution" on page 18. We will 
not receive any of the proceeds.

       Our common stock is quoted on the OTC Bulletin Board under the symbol 
"ATEG."  On March 1, 1999, the closing sale price of the common stock on the 
OTC Bulletin Board was $0.52.

       INVESTING IN OUR COMMON STOCK INVOLVES SUBSTANTIAL RISKS.
       SEE "RISK FACTORS" BEGINNING ON PAGE 7.



       NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE
       SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE
       SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE
       PROSPECTUS.  ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
       OFFENSE.



                  The date of this prospectus is March 3, 1999.
    
<PAGE>
   
                                 TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                         Page
                                                         ----
<S>                                                      <C>
ABOUT AMERICAN TECHNOLOGIES...............................4

       Business Summary...................................4
       Current Financing..................................6
       Proposed Merger with Commodore Separation 
       Technologies, Inc..................................6
RISK FACTORS..............................................7

Financial Risk Factors....................................7

       We Have a History of Losses Which Will 
       Likely Continue Through the End of the 
       Current Fiscal Year................................7
       We have Experienced Substantial Difficulty
         Generating Sufficient Working Capital and 
         If We Do Not Receive Additional Money by 
         April 1999 We Will Not be Able to Continue 
         to Operate.......................................8
       Our Sales of Securities Convertible into
         Common Stock at a Discount to the Market
         Price May Cause the Market Value of Our
         Common Stock to Drop.............................8
       Lack of Listing on a Major Exchange May Make
         It Difficult for Investors to Dispose of
         Our Common Stock.................................9
       We May become a Penny Stock Resulting in 
         Reduced Willingness of Broker-Dealers 
         To Trade Our Common Stock........................9
       We May Not Have Sufficient Funds With Which 
         to Operate.......................................9

Business Risk Factors....................................10

       We May Not Find Customers for Our Products........10
       The Scientific Community May Not Provide 
         Sufficient Validation of Our Products to 
         Encourage Sales.................................11
       There May Be Unforeseen Regulatory Requirements
         which Impede the Marketing and Sale of
         our Products....................................11
       We May Not Be Able to Obtain the Patents or
         Trademarks Needed to Protect The Value
         of Our Technologies.............................11
</TABLE>
    
                                       2

<PAGE>

   

<TABLE>
<CAPTION>

<S>                                                      <C>
WHERE YOU CAN FIND MORE INFORMATION......................13

FORWARD-LOOKING STATEMENTS...............................14

USE OF PROCEEDS FROM SALE OF COMMON STOCK................14

USE OF PROCEEDS FROM SALE OF DEBENTURES..................14

USE OF PROCEEDS FROM EXERCISE OF WARRANTS................14

SELLING SECURITYHOLDERS..................................15

PLAN OF DISTRIBUTION.....................................18

INDEMNIFICATION FOR SECURITIES ACT LIABILITIES...........20

EXPERTS..................................................20

LEGAL MATTERS............................................20

</TABLE>
    
                                       

<PAGE>
   
                            ABOUT AMERICAN TECHNOLOGIES

Business Summary

       American Technologies develops and sells products based upon on our 
patented and proprietary technologies.  The goal of our efforts is to develop 
products that have a positive impact on the environment.  Our address and 
telephone number are: 1017 South Mountain Avenue, Monrovia, California  
91016, (626) 357-5000.

       We concentrate on technology discovery and development efforts in 
three areas:  

I(E)-TM- Technology
Water Purification
Particle Beams

       Our I(E) Technology refers to a proprietary process which produces 
water solutions containing water clusters that are stable at room 
temperature. The clusters are groups of water molecules configured in such a 
way so as to produce relatively large plus/minus polarity. We believe this 
polarity is what gives the clusters their catalytic properties. We can 
produce different kinds of water solutions for different applications.

       Tests indicate that these water clusters improve the performance of 
various chemical, physical and biological processes, including combustion 
enhancement, descaling, enzyme processes and de-coking. For example, in 
internal combustion engines the clusters attract hydrocarbon and oxygen 
resulting in a more complete burning of the fuel. This results in improved 
efficiency and reduced carbon deposits in the combustion chamber. In certain 
biological applications related to enzyme production, the clusters have been 
shown to significantly improve enzyme yield.

       Independent researchers observe these water clusters by different 
standard research tools including:

    

Laser autocorrelation
Electron microscope
Atomic force microscope
UV spectroscopy

                                       3

<PAGE>

   
       American Technologies sells these water solutions for use in several 
product lines including household cleaning products and cosmetics.  We also 
use them in our combustion enhancers.

       During the fiscal year ended July 31, 1998, revenue from the sale of 
these water solutions for use in products manufactured by others was 
approximately $117,000 and revenue from the sale of The Force-Registered 
Trademark- combustion enhancer was $591,000. During the same period, 
American Technologies had incurred net losses of approximately $9.64 million. 
If we do not sell any additional securities and sales do not increase 
significantly, we will be out of money by April, 1999.

Kinetics Technology International Corporation has conducted field tests on 
the use of I(E) Technology as a coke formation suppresser.  Kinetics 
Technology has funded the testing and, if the testing is successful, will 
have financial responsibility for commercialization of the final product.  
There can be no assurance
    
                                       

<PAGE>
   

that the I(E) Technology can suppress coke formation and whether, if it does 
do so, if it does so in a commercially viable manner.

       In the water purification area, our low pressure vacuum distillation 
system is undergoing tooling design for a home use version for introduction 
to the marketplace in mid-1999.  Our vacuum distiller utilizes a proprietary 
method to provide the advantages of vacuum distillers without the need for 
expensive and noisy vacuum pumps.

       Under our agreement with Sunpentown, Ltd. for the tooling design and 
manufacturing of the distiller, they are responsible for all design costs and 
the cost of producing the tooling. Our marketing plan for the distiller 
involves establishing relationships with distributors experienced in this 
type of product. We do not anticipate incurring significant marketing costs 
for this product.

       The third technology is the particle beam project which produces a 
beam of heavy particles.  As a beam of particles, it functions in much the 
same way as the common laser.  The important difference is that it is 
composed of heavy particles rather than light.  

       The development of the particle beam is being conducted through an 
American Technologies sponsored research program with the California 
Institute of Technology.  The development of this technology is likely to 
require a minimum of three to five years and expenditure of substantial sums 
of money, likely to be in excess of $10,000,000, on research and development. 
 We submitted a proposal to the Department of Energy for a $5,000,000 joint 
venture grant to produce a small pilot plant based on the current prototype 
located at CalTech.  The proposal describes the potential of our particle 
beam to turn harmful nuclear waste into harmless components.  The DOE is 
reviewing the proposal.

       Dr. Lo, our Director of Research and Development, has developed 
certain particle beam theories. According to these theories, the proposed 
particle beam may be able to break down molecules or even atoms and their 
nuclei, or be used for rock drilling, medical surgery or precision cutting of 
metals without distortion or excessive heat.  No evidence exists to 
substantiate these potential applications.

Current Financing

       From October, 1998, through February, 1999, we sold to 8 investors 
$1,600,000 principal amount of debentures in a private placement. In 
connection with the sale of the debentures we are obligated to register with 
the SEC within 90 days the shares of common stock issuable on conversion of 
the debentures and exercise of the warrants issued with the debentures. If the 
registration statement is not declared effective by the SEC within this 90 
day period, we must pay liquidated damages to the investors. For the first 30 
days we are late the damages are 2% of the principal amount invested. 
Starting 120 days after the purchase of the debentures the damages are 3% per 
month. Through February 28, 1999, we have incurred approximately $10,300 in 
liquidated damages.

       We are currently negotiating for a commitment from International 
Investment Group to provide additional financing in the amount of up to 
$5,000,000. The specific structure and terms of the financing is undetermined 
at this time. Further, in connection with the proposed merger of American 
Technologies with Commodore Separation Technologies, Inc., we may receive 
certain bridge financing in the amount of $1,300,000.  There can be no 
assurance that we will obtain the commitment from International Investment 
Group or complete the merger with Commodore and receive the bridge financing.

Proposed Merger with Commodore Separation Technologies, Inc.

       We recently signed a letter of intent which effectuates our acquisition 
of Commodore Separation Technologies, although the transaction is structured 
as a merger. Commodore Separation Technologies is commercializing a 
proprietary separation technology and recovery system known as SLiM -TM-. SLiM 
stands for Supported Liquid Membrane. SLiM can selectively remove from water 
valuable substances for reuse or toxic materials for safe disposal.

       If the transaction is completed as proposed, the existing shareholders 
of American Technologies would own approximately 80.1 percent of the 
surviving company and the shareholders of Commodore Separation Technolgies 
would own approximately 19.1 percent of the surviving company. In addition, 
the Commodore Separation Technologies shareholders will receive one third of 
the after tax profit of the existing business of Commodore Separation 
Technologies.

       One of the conditions to the completion of the merger is our receipt 
of $1.3 million in net proceeds from bridge financing and a proposal for 
permanent financing of $7 million. Specific sources and terms for these 
financings have not been determined although negotiations are ongoing with 
several sources of funds.

    
                                       4

<PAGE>

   
                                    RISK FACTORS

You should carefully consider the risks described below before making an
investment decision.  The risks and uncertainties described below are not the
only ones facing our company.  Additional risks and uncertainties not presently
known to us or that we currently deem immaterial may also impair our business
operations.

If any of the following risks actually occur, our business, financial condition
or results of operations could be materially adversely affected.  In such case,
the trading price of our common stock could decline, and you may lose all or
part of your investment.

Financial Risk FACTORS

WE HAVE A HISTORY OF FINANCIAL LOSSES WHICH WILL LIKELY CONTINUE THROUGH 
THE END OF THE CURRENT FISCAL YEAR.

       We have operated at a loss throughout our history.  Net losses for the 
fiscal year ended July 31, 1998 were approximately $9.44 million.  Net losses 
for the fiscal year ended July 31, 1997 were approximately $9.64 million.  At 
July 31, 1998 we had an accumulated deficit of $36.56 million.

While we anticipate that we will reduce the level of our operating losses by 
the end of the fiscal year ending July 31, 1999, there can be no guarantees 
that this will occur.  The amount of net losses and the time required to 
reach profitability are uncertain.  There can be no assurance that we will 
ever be able to generate sufficient revenue from our products now ready for 
market or those under development to achieve profitability on a sustained 
basis.  See the Management's Discussion and Analysis section of Amendment No. 
2 to our Form 10-KSB/A.

WE HAVE EXPERIENCED SUBSTANTIAL DIFFICULTY GENERATING SUFFICIENT WORKING 
CAPITAL AND IF WE DO NOT RECEIVE ADDITIONAL MONEY BY APRIL, 1999 WE WILL NOT 
BE ABLE TO CONTINUE TO OPERATE

American Technologies has been experiencing difficulty in maintaining 
sufficient working capital needed to insure stability and continued 
existence.  Only a small portion of the capital expended to date has come 
from actual revenue generation, and we find it increasingly difficult to 
raise investment capital. We are at a critical juncture in our history.  It 
is absolutely essential to begin to generate significant revenues in order to 
maintain our existence. While plans are in place and being executed directed 
at accomplishing this end, there can be no guarantee that these plans will 
prove to be successful.

    
                                       5

<PAGE>

   
       Our monthly operating expenses are approximately $330,000.  If we do not
sell any additional securities and sales do not increase significantly, we will
be out of money by April, 1999.

Our auditors' report on our financial statements for the fiscal year ending 
July 31, 1998 contains an explanatory paragraph indicating that there were 
operating losses which raised substantial doubt about the ability of American 
Technologies to continue as a going concern.  This going concern 
qualification may adversely affect our perception by prospective customers 
and suppliers.  

OUR SALES OF SECURITIES CONVERTIBLE INTO COMMON STOCK AT A DISCOUNT TO THE 
MARKET PRICE MAY CAUSE THE MARKET VALUE OF OUR COMMON STOCK TO DROP

       As a result of our poor financial condition, several times over the past
few years we have sold securities that are convertible into our common stock at
a discount to the market price for the common stock.  This has resulted in the
issuance of a significant amount of additional shares of common stock at prices
below market.  It is possible that this method of financing operations has
contributed to the decline in the market price of the common stock.  If we need
to obtain financing in the future in the same manner, this may again have an
adverse affect on the market price for our common stock.

       The terms and structure of up to an additional $5,000,000 in financing 
currently under discussion with the International Investment Group are not 
yet determined. The completion of this financing may have an adverse affect 
on the market price for the common stock.

    

                                       6

<PAGE>

   

LACK OF LISTING ON A MAJOR EXCHANGE MAY MAKE IT DIFFICULT FOR INVESTORS 
TO DISPOSE OF OUR COMMON STOCK.

Our common stock is quoted on the OTC Bulletin Board system.  The OTC 
Bulletin Board generally supports quotations for companies that do not meet 
the NASDAQ SmallCap Market listing requirements.  As a result, investors may 
find it more difficult to dispose of or to obtain accurate price quotations 
of our common stock than they would if the stock were quoted on the SmallCap 
Market. In addition, quotation on the bulletin board depends on the 
willingness of broker-dealers to make a market in our common stock.  There 
can be no assurance that the stock will continue to be quoted on the bulletin 
board or that there will continue to be a market for the buying and selling 
of our common stock.

       There are currently 15 firms making a market in our common stock. The 
firms are:

J. Alexander Securities, Inc.                        Knight Securities, L.P.
Wm. V. Frankel & Co., Incorporated                   Sharpe Capital, Inc.
Speer, Leeds & Kellogg Capital Markets               Sherwood Securities Corp.
Hill Thompson Magid & Co. Inc.                       Wien Securities Corp.
Herzog, Heine, Geduld, Inc.                          Wilson-Davis & Co., Inc.
North American Institutional Brokers                 Mayer & Schweitzer, Inc.
M. H. Meyerson & Co., Inc.                           GVR Company
USCC Trading/A Division of
     Fleet Securities

    

                                       

<PAGE>
   

WE MAY BECOME A PENNY STOCK RESULTING IN REDUCED WILLINGNESS OF 
BROKER-DEALERS TO TRADE OUR COMMON STOCK

If our net tangible assets fall below $2 million at July 31, 1999 or if we 
otherwise fail to meet certain criteria of the Commission, the common stock 
becomes subject to so-called "penny stock" rules that impose additional sales 
practice and market making requirements on broker-dealers who sell and/or 
make a market in such securities.  These rules may discourage the ability or 
willingness of broker-dealers to sell and/or make a market in our common 
stock.

WE MAY NOT HAVE SUFFICIENT FUNDS WITH WHICH TO OPERATE

We expect that our current cash, existing financing agreements and minimum 
expected sales revenue will be sufficient to fund our operations through 
April, 1999.  During this time it is essential that we obtain additional 
financing or be successful in the commercialization of our products, and 
there is no guarantee that this will occur. Revenues during the fiscal year 
ended July 31, 1998 were approximately $916,700 and revenues for the quarter 
ended October 31, 1998 were approximately $166,000.  In order to achieve 
viability, management currently estimates that revenues will have to increase 
to at least $4.2 million annually, based upon our anticipated working capital 
and cash flow requirements. We believe that this minimum level of sales will 
not be sufficient to achieve current profitability, but will allow us to 
continue operations without obtaining immediate additional debt or equity 
financing.

Our exact future capital requirements depend on numerous factors, including 
the amount of revenues generated from operations, cost of sales and marketing 
activities and the progress of our research and development activities.  We 
are currently negotiating for a commitment from International Investment 
Group to purchase additional debentures in the aggregate principal amount of 
up to $5,000,000.  There can be no assurance that such funding will be 
available on acceptable terms, or at all, when it is required.  If additional 
funding is not available when needed, it is possible that we would have to 
reduce or suspend operations, seek an acquisition partner, or sell securities 
on terms that might be highly dilutive or otherwise disadvantageous to 
investors.

BUSINESS RISK FACTORS

As American Technologies is engaged in the development and marketing of 
products based on new technologies, there are significant risks associated 
with its potential success.

    

                                       7

<PAGE>

   

WE MAY NOT FIND CUSTOMERS FOR OUR PRODUCTS

None of our current products enjoy widespread distribution or customer 
acceptance.  While we do have a number of products that are past the 
development stage, we have yet to establish major, stable markets for them.  
Although we believe we have the expertise to commercialize these products, 
any or all of our products may fail to prove to have widespread customer 
appeal.  Various marketing strategies and alliances are now in place.  To 
assist in the marketing of The Force and other products we have established a 
relationship with Comtrad Industries.  The marketing of certain household 
cleaning products and cosmetics containing I(E) water solutions is being 
conducted by 21st Century Global Network, LLC. We are a founding member of 
21st Century.  Kinetics Technology is doing the field tests, and if 
successful, will market an I(E) water solution product as a coke formation 
suppressor.

THE SCIENTIFIC COMMUNITY MAY NOT PROVIDE SUFFICIENT VALIDATION OF OUR 
PRODUCTS TO ENCOURAGE SALES

Our technologies have not received broad acceptance by the general scientific 
community.  To a great extent, scientific validation of our technologies is 
essential to acceptance of the products by the marketplace.  Historically, 
the scientific community has been resistant to new ideas and technologies, 
and, although we believe that we have been successful in establishing working 
relationships with many scientists at prestigious academic institutions, 
there is no guarantee that this will lead to acceptance of our technologies 
by the scientific community as a whole.  Failure to achieve such acceptance 
could be materially detrimental to our efforts to establish markets for our 
products.

THERE MAY BE UNFORSEEN REGULATORY REQUIREMENTS WHICH IMPEDE THE MARKETING AND 
SALE OF OUR PRODUCTS

       Most of our current products are being sold directly to the consumer in
markets that are not generally regulated by government agencies.  In the case of
consumer products for enhancing engine performance, such as The Force or the
F420 fuel 

    

                                       8

<PAGE>
   
additive, registration of these products with CARB (California Air Resources
Board) and EPA (Environmental Protection Agency) is required and has been done.

       Since the F420 additive's chemical contents fall within the restrictions
of the EPA regulations, there are no known impediments to maintaining this
registration.  We have also registered The Force airborne combustion enhancer as
an add-on device with CARB.  There is no known reason why CARB would withdraw
that registration.

       In the case of bulk fuel additives, there are strong industry
regulations.  Extensive testing is required to meet these industry regulations
prior to sale of the additive and there is no guarantee that our bulk additive
products can meet all of these industry regulations.

WE MAY NOT BE ABLE TO OBTAIN THE PATENTS OR TRADEMARKS NEEDED TO PROTECT THE 
VALUE OF OUR TECHNOLOGIES

       Our success will depend, in part, on whether we can obtain patent and
trademark protection for our technologies and products.  We cannot guarantee
that we will be able to secure these protections.  If we fail to do so, there is
no guarantee that our technologies will not be subject to copying by other
entities.  This would result in a level of competition which could well prevent
us from being successful.  Although we have taken steps, including entering into
confidentiality agreements with our employees and third parties to protect our
trade secrets and unpatented know-how, other third parties may still be able to
obtain such information. 

       We have applied for a number of patents on our particle beam and I(E) 
technologies.  Some have been approved.  The status is as follows:

   -   Particle Beam Approved Patents
There are 8 approved U.S. patents and 9 foreign patents issued on particle beam
technology.  There are 3 additional U.S. patent applications pending.
   -   I(E) Technology
There is 1 granted U.S. patent, not yet issued, on the I(e) Technology and 10
other U.S. patent applications in various stages of prosecution.
   -   Vacuum Distiller
There are 3 U.S. patent applications pending on the vacuum distiller technology.
Foreign applications to protect the 

                                       9
    
<PAGE>
   
technology are also in process.  No patents have been granted yet.

       All of our products currently offered for sale are protected by patents
in the U.S.  The group of patent applications currently in process have
sufficient overlap to offer protection to our current commercial applications. 
We file applications with the U.S. Patent and Trademark Office once we perceive
a new significant commercial application, and prior to public disclosure of the
application.


WHERE YOU CAN FIND MORE INFORMATION

       We file annual, quarterly and special reports, proxy statements and other
information with the SEC. You may read and copy any document we file at the
SEC's public reference rooms in Washington, D.C., New York, New York and
Chicago, Illinois. Please call the SEC at 1-800-SEC-0330 for further information
on the public reference rooms.  Our SEC filings are also available to the public
from our web site at www.ateg.com or at the SEC's web site at www.sec.gov.

       The SEC allows us to "incorporate by reference" the information we file
with them, which means that we can disclose important information to you by
referring you to those documents.  The information incorporated by reference is
considered to be part of this prospectus, and later information that we file
with the SEC will automatically update and supersede this information.  We
incorporate by reference the documents listed below and any future filings made
with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Securities
Exchange Act of 1934 until the selling securityholders sell all the shares. 
This prospectus is part of a registration statement we filed with the SEC
(Registration No. 333-6827).

       The following documents are hereby incorporated by reference in this
Registration Statement:

   -   Annual Report on Form 10-KSB for the year ended July 31, 1998.

   -   Amendment Number 1 to our Annual Report on Form 10-KSB/A for the year
       ended July 31, 1998.

   -   Amendment Number 2 to our Annual Report on Form 10-KSB/A for the year
       ended July 31, 1998.

   -   Quarterly Report on Form 10-QSB for the three months ended 
       October 31, 1998.

   -   Amendment Number 1 to our Quarterly Report on Form 10-QSB/A for the 
       three months ended October 31, 1998.

   -   Current Report of Form 8-K dated January 5, 1999.

                                       10
    
<PAGE>
   
   -   The section of our Registration Statement on Form 10, filed on January
       24, 1994, entitled "Description of Securities," as amended by Amendment
       Nos. 1, 2, 3 and 4.

You may request a copy of these filings, at no cost, by writing or telephoning
us at the following address:

       Corporate Secretary
       American Technologies Group, Inc.
       1017 South Mountain Avenue
       Monrovia, California 91016
       (626) 357-5000

You should rely only on the information incorporated by reference or provided in
this prospectus or any supplement.  We have not authorized anyone else to
provide you with different information.  The selling securityholders will not
make an offer of these shares in any state where the offer is not permitted. 
You should not assume that the information in this prospectus or any supplement
is accurate as of any date other than the date on the front of such documents.


FORWARD-LOOKING STATEMENTS

       We have made forward-looking statements in this prospectus and in the
documents that are incorporated by reference. Forward-looking statements are
subject to risks and uncertainties and include information concerning possible
or assumed future results of our operations.  When we use words such as
"believes," "expects," "anticipates" or similar expressions, we are making
forward-looking statements.  You should note that an investment in our
securities involves certain risks and uncertainties that could affect our future
financial results.  Our actual results could differ materially from those
anticipated in these forward-looking statements as a result of certain factors,
including those set forth in "Risk Factors" and elsewhere in this prospectus.


USE OF PROCEEDS FROM SALE OF COMMON STOCK

       American Technologies will not receive any of the proceeds from the sale
of the shares of common stock by the selling security holders.


USE OF PROCEEDS FROM SALE OF DEBENTURES

       We have received $1,600,000 from the sale of the debentures.

    
                                       11

<PAGE>

   

We have used and will continue to use the net proceeds from the sale of the 
debentures for working capital and the payment of existing liabilities.

USE OF PROCEEDS FROM EXERCISE OF WARRANTS

       If all of the warrants are exercised, we will receive $159,375.  We 
intend to use these funds for working capital and the payment of existing 
liabilities.

SELLING SECURITYHOLDERS


Selling Securityholders

       The following table identifies certain selling securityholders along 
with the principal amount of debentures and the number of warrants they own.

<TABLE>
<CAPTION>
                                   Principal
                                    AMOUNT OF           NUMBER OF
            NAME                   DEBENTURES           WARRANTS
            ----                   ----------           ---------
<S>                                <C>                  <C>
International Investment           $ 200,000              20,000
Group Equity Fund, NV


Venezuela Recovery Fund            $  50,000               5,000


Britannia Associates Limited       $ 375,000              37,500


JRT Holdings                       $  25,000               2,500


Cinzia Santa Rossa                 $ 250,000              25,000


Intermediazioni                    $  50,000               5,000
Internazionali S.A.


Spiga Limited                      $ 100,000              62,500


Gaines P. Campbell, Jr.            $ 550,000              55,000
</TABLE>

                                       12
    
<PAGE>
   
Conversion of Debentures

       The selling securityholders may convert or exchange their debentures 
for shares of our common stock by giving written notice to us.  $1,050,000 of 
the debentures are convertible at a variable conversion price depending upon 
the market price for our common stock on the date of conversion.  There is a 
maximum conversion price of $0.62 but no minimum conversion price.  $250,000 
of debentures have a fixed conversion price of $0.58 and $300,000 of 
debenture have fixed conversion price of $0.50.

Variable Conversion Price

       The variable conversion price is the lesser of

$0.62; or 

75% of the average closing bid price for the common stock during the five
trading days ending one day prior to conversion of the debenture.  

Estimate of Shares Issuable Upon Conversion

       If all of the debentures were converted on February 26, 1999, the 
variable conversion price would be $0.414 and the total number of shares of 
common stock issued would be 3,567,267.  This does not include any shares of 
common stock issued as interest due on the debentures.  $1,050,000 in 
principal amount of the debentures bear interest at 6% per annum and $550,000 
in principal amount of the debentures bear interest at 3% per annum.

       The following table contains the names of the selling securityholders, 
the number of shares of common stock owned beneficially by each of the 
selling securityholders as of February 26, 1999, and the number of shares 
which may be offered for resale under this prospectus.  For the purpose of 
stating the number of shares of common stock beneficially owned by the 
selling securityholders in the following table, the number of shares of 
common stock calculated to be issuable in connection with the conversion of 
the debentures assumes the debentures were converted on February 26, 1999.  
This calculation results in an estimate of the number of shares of common 
stock issuable upon conversion of the debentures.

       The information included in the following table is based upon 
information provided by the selling securityholders.  Because the selling 
securityholders may offer all, some or none of their common stock, no 
definitive estimate as to the number of shares that will be held by the 
selling securityholders after the offering can be provided and the following 
table has been 

    

                                       13

<PAGE>
   
prepared on the assumption that all shares of common stock offered under this
prospectus will be sold.

<TABLE>
<CAPTION>
                                     SHARES OF                                 SHARES OF
                                   COMMON STOCK                              COMMON STOCK
                                   BENEFICIALLY           SHARES OF          BENEFICIALLY
NAME AND                          OWNED PRIOR TO        COMMON STOCK          OWNED AFTER
ADDRESS                           OFFERING (1)(2)       BEING OFFERED         OFFERING (3)
- -------                           ---------------       -------------        -------------
<S>                               <C>                   <C>                  <C>
Int'l Investment (4)                  398,788             398,788                   0
Group Equity Fund 

Venezuela Fund (4)                     99,697              99,697                   0

Britannia Associates(4)               747,727             747,727                   0

JRT Holdings                           49,848              49,848                   0
c/o Astor Capital
9300 Wilshire Blvd.,
Suite 308
Beverly Hills, CA  90212

Cinzia Santa Rossa                    498,485             498,485                   0
Via Martiri/
Villa Liberta 45
Prato di Pordenone 33080
Pordenone, Italia

Intermediazioni                        99,697              99,697                   0
Internazionali S.A.
Pasea Estate, Road Town
Tortola BVI

Spiga Ltd.                            251,894             251,894                   0
Skelton Building
Road Town, Tortola BVI

Gaines P. Campbell, Jr.             1,031,034           1,031,034                   0
1341 Birmingham Highway
Chattanoga, TN 37419

MacLaughlin Trade Development         500,000             500,000                   0
5263 Heather Lane
Park City, Utah 84098

Born Enterprises                      300,000             200,000             100,000
60 S.E. 6th Avenue
Delray Beach, FL 33483

</TABLE>

(1)  Each of the parties listed has sole voting and investment power for all 
of the shares of common stock indicated.

(2)  As required by the regulations of the SEC, the number of shares shown as 
beneficially owned includes shares which can be purchased within 60 days 
after February 4, 1999.  The actual number of shares shown is subject to 
adjustment and could be materially less or more than the estimated amount 
indicated depending upon factors which we cannot predict such as the market 
price of the common stock on the actual date of conversion of the debentures.

(3)  Assumes the sale of all shares offered.

(4)  The address of each of these selling securityholders is c/o 
International Investment Group, 17 State Street, NY, NY  10004

    

                                       14

<PAGE>
   
Registration Rights

       The subscription agreements for the sale of the debentures require us 
to register with the SEC the public offering of the shares of common stock 
issuable on conversion of the debentures and exercise of the warrants.  We 
are also obligated to register and qualify the shares under such state 
securities laws as the selling securityholders may request.

       We are obligated to use our best efforts to cause the registration 
statement to become effective and to keep the registration statement 
effective for two years or until the selling securityholders may sell all 
registerable securities under Rule 144 or until the debenture holders no 
longer own any shares, whichever occurs first.

       The subscription agreements provide for liquidated damages to the 
debenture holders if we are unable to have the registration statement 
declared effective by the SEC within 90 days from the date of sale of the 
debentures.  We have passed this deadline as to $650,000 in principal amount 
of debentures.  The amount due in liquidated damages is $10,300 payable in 
cash or common stock valued at the lower of current market value or $0.62.

       In connection with our private placement of $1,600,000 principal 
amount of debentures, we issued warrants to purchase 160,000 shares of Common 
Stock to the debenture holders and warrants to purchase 52,500 shares of 
common stock to Spiga Ltd., our selling agent, at $0.75, all for a period of 
5 years.  Spiga also purchased $100,000 principal amount of debentures.

PLAN OF DISTRIBUTION

       The selling securityholders may offer the shares of common stock received
upon conversion of the debentures or exercise of the warrants at various times
in transactions:

       - in the over-the-counter market;

       - on any exchange where our common stock is then listed;

       - with broker-dealers or third parties other than in the over-the-counter
market or on an exchange, including block sales; or

       - involving a combination of such methods or other methods.

                                       15
    
<PAGE>
   
       The selling securityholders may sell their shares at market prices
prevailing at the time of sale, at prices related to such prevailing market
prices, at negotiated prices, at fixed prices or at a combination of such
prices.

       The selling securityholders may use dealers, agents or underwriters to
sell their shares.  If this happens, the dealers, agents or underwriters may
receive compensation in the form of discounts or commissions from the selling
securityholders or from the purchasers of shares or from both.  The compensation
to a particular broker may be in excess of customary compensation.

       The selling securityholders and any dealers, agents or underwriters that
participate with the selling securityholders in the distribution of the shares
may be deemed to be "underwriters" as this term is defined in the Securities
Act.  Any commissions paid or any discounts or concessions allowed to any such
persons, and any profits received on the resale of the shares of our common
stock offered by this prospectus, may be deemed to be underwriting commissions
or discounts under the Securities Act.

       Broker-dealers may agree with a selling securityholder to sell a 
specified number of shares at a stipulated price, and, to the extent the 
broker-dealer is unable to do so acting as agent for the selling 
securityholder, to purchase as principal any unsold shares at the price 
required to fulfill the broker-dealer's commitment to the selling 
securityholder.  Broker-dealers who acquire shares as principal may 
thereafter resell the shares in transactions on the OTC Bulletin Board, in 
negotiated transactions or otherwise at market prices prevailing at the time 
of sale or at negotiated prices.  These transactions may involve crosses and 
block transactions or sales to and through other broker-dealers.  In 
connection with these resales broker-dealers may pay to or receive 
commissions from the purchasers of the shares.

       We will pay most expenses related to the offer and sale of the shares 
offered by the selling securityholders using this prospectus.  The selling 
securityholders, however, will pay any underwriting discounts and selling 
commissions and the fees of their own attorneys.

       Any shares covered by this prospectus which qualify for sale under 
Rule 144 of the Securities Act may be sold under that Rule rather than under 
this prospectus.

    
                                       16

<PAGE>

   
INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

Our Amended Bylaws provide that we shall indemnify our directors and officers to
the fullest extent permitted by Nevada law, including circumstances in which
indemnification is otherwise discretionary under Nevada law. 

In addition, American Technologies and each selling securityholder have agreed
to indemnify each other against certain liabilities, including certain
liabilities under the Securities Act.

Insofar as indemnification for liabilities arising under the Securities Act may
be permitted to our directors, officers and controlling persons, we been advised
that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable.


EXPERTS

Our audited financial statements as of and for the years ended July 31, 1998 
and 1997 incorporated by reference in this prospectus and elsewhere in this 
registration statement have been audited by Arthur Andersen LLP, independent 
public accountants, as indicated in their report with respect thereto, and 
are incorporated herein by reference in reliance upon the authority of said 
firm as experts in giving said reports.  Reference is made to said report, 
which includes an explanatory paragraph with respect to the uncertainty 
regarding our ability to continue as a going concern as discussed in Note 1 
to the financial statements.

LEGAL MATTERS

       For the purpose of this offering, John M. Dab, our General Counsel, is
giving his opinion on the validity of the shares.

                                       17
    
<PAGE>
   
PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 14.  OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.*

<TABLE>
<S>                                <C>
SEC Registration Fee               $   752.44
Accountant's Fees and Expenses     $ 6,000.00
Financial Printers                 $ 4,000.00
Miscellaneous                      $   500.00

Total                              $11,252.44
                                   ----------
                                   ----------
</TABLE>
- ----------------
*  Represents expenses relating to the distribution by the selling 
securityholders under this prospectus prepared in accordance with the 
requirements of Form S-3.  These expenses will be borne by us on behalf of 
the selling securityholders.  All amounts are estimates except for the SEC 
Registration Fee.

ITEM 15.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.

       As permitted by Section 78.751 of the Nevada General Corporation Law,
Article VI of our Amended Bylaws provides for the indemnification by American
Technologies, including suits brought by or on behalf of American Technologies,
of each director, officer, employee or agent thereof to the fullest extent
permitted by Nevada law.
 
       As permitted by the Nevada General Corporation Law and Article VI of our
Amended Bylaws, maintains director's and officer's liability for its directors
and officers against certain liabilities.

ITEM 16.  EXHIBITS.

<TABLE>
<CAPTION>
Exhibit
Numbers    Description
- -------    -----------
<S>        <C>
 4.1       Form of 6% Convertible Debenture issued to certain Selling 
           Securityholders. (1)

 4.2       Form of Warrant issued to certain Selling Securityholders. (1)

 4.3       Form of 3% Convertible Debenture issued to a Selling 
           Securityholder. (2)

 5.1       Opinion of John M. Dab.

23.1       Consent of John M. Dab (included in Exhibit 5.1).
</TABLE>
                                       18
    
<PAGE>
   
<TABLE>
<S>        <C>
23.2       Consent of Arthur Andersen LLP.

24.1       Power of Attorney (1)
</TABLE>
- ---------------

(1)    Previously filed as an exhibit to the Company's Registration
Statement on Form S-3 filed with the Securities and Exchange Commission
on December 3, 1998.

(2)    Previously filed as an exhibit to Amendment No. 1 to the Company's 
Registration Statement on Form S-3 filed with the Securities and Exchange 
Commission on February 10, 1998.

ITEM 17.  UNDERTAKINGS.

(a)    The undersigned Registrant hereby undertakes:

1)  To file, during any period in which offers or sales are being made, a 
post-effective amendment to this Registration Statement to include any 
material information with respect to the plan of distribution not previously 
disclosed in the Registration Statement or any material change to such 
information in the Registration Statement.

(2)  That, for the purpose of determining any liability under the Securities
Act, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at the time shall be deemed to be the initial bona fide offering
thereof.

(3)  To remove from registration by means of a post-effective amendment any of
the securities being registered which remain unsold at the termination of the
offering.

(b)    The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
Registrant's annual report pursuant to section 13(a) or section 15(d) of the
Exchange Act (and, where applicable, each filing of an employee benefit plan's
annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in the Registration Statement shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be an initial bona
fide offering thereof.

(c)    Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the Nevada Revised Statutes, the Certificate of
Incorporation of the Registrant, the Bylaws of the Registrant, Indemnification
Agreements entered into between the Registrant and it officers and directors, or
otherwise, the Registrant has been advised that in the opinion of the Securities
and Exchange Commission such 

                                       19
    
<PAGE>
   
indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable.  In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by the controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of the such issue.


SIGNATURES

       Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Monrovia, State of California, on this 2nd day of 
March, 1999.

                                   AMERICAN TECHNOLOGIES GROUP, INC.

                                   By: /s/Lawrence J. Brady
                                       -------------------------
                                      Lawrence J. Brady
                                      Chairman of the Board and
                                      Chief Executive Officer

                                       20
    
<PAGE>
   
Pursuant to the requirements of the Securities Act of 1933, this Registration
Statement has been signed below by the following persons in the capacities
indicated.

<TABLE>
<CAPTION>
       Signature                   Title                         Date
       ---------                   -----                         ----
<S>                           <C>                           <C>

/s/Lawrence J. Brady          Chairman of the Board,        March 2, 1999
- --------------------------    Chief Executive Officer
Lawrence J. Brady


/s/Harold Rapp                Chief Operating Officer       March 2, 1999
- --------------------------    Treasurer (Principal 
HAROLD RAPP                   Financial and Accounting 
                              Officer)


/s/Shui Yin Lo                Director of Research and      March 2, 1999
- --------------------------    Development and a Director
SHUI YIN LO


/s/Charles McCarthy*          Director                      March 2, 1999
- --------------------------
CHARLES MC CARTHY


/s/William Odom*              Director                      March 2, 1999
- --------------------------
WILLIAM ODOM


- --------------------------    Director
TERRY WACHSNER


*By: /s/Lawrence J. Brady
    ----------------------
    Lawrence J. Brady
    Attorney-in-Fact
</TABLE>
                                       21
    
<PAGE>
   

INDEX TO EXHIBITS

<TABLE>
<CAPTION>
Exhibit
Numbers     Description
- -------     -----------
<S>     <C>
 4.1    Form of 6% Convertible Debenture issued to the Selling 
        Securityholders. (1)

 4.2    Form of Warrant issued to the Selling Securityholders. (1)

 4.3    Form of 3% Convertible Debenture issued to a Selling 
        Securityholders. (2)

 5.1    Opinion of John M. Dab.

23.1    Consent of John M. Dab (included in Exhibit 5.1).

23.2    Consent of Arthur Andersen LLP.

24.1    Power of Attorney (1)
</TABLE>
- ---------------
(1)     Previously filed as an exhibit to the Company's Registration 
Statement on Form S-3 filed with the Securities and Exchange Commission 
on December 3, 1998.

(2)     Previously filed as an exhibit to Amendment No. 1 to the Company's 
Registration Statement on Form S-3 filed with the Securities and Exchange 
Commission on February 10, 1999.

    
                                       22


<PAGE>



                                    EXHIBIT 5.1



                                                              March 3, 1999


Board of Directors
American Technologies Group, Inc.
1017 S. Mountain Ave.
Monrovia, California  91016


Gentlemen:

     As General Counsel for American Technologies Group, Inc. (the 
"Company"), in connection with the Registration Statement on Form S-3 (the 
"Registration Statement") to be filed with the Securities and Exchange 
Commission on or about March 3, 1999 intended to register 3,560,000 shares of 
the common stock of the Company issuable upon the conversion of $1,600,000 
principal amount of its convertible debentures, 212,500 shares of common 
stock of the Company issuable upon the exercise of its common stock purchase 
warrants and an additional 700,000 shares of common stock (collectively, the 
"Shares"), as more fully described in the Registration Statement, I have 
examined such corporate records and other documents and such questions of law 
as I have considered necessary or appropriate for the purposes of this 
opinion and, on the basis of such examination, advise you that in my opinion 
the Shares will be, when issued as specified in the Registration Statement, 
validly issued, fully paid and nonassessable.

     I hereby consent to the filing of this opinion as an Exhibit to the
Registration Statement.  This consent is not to be construed as an admission
that I am a person whose consent is required to be filed with the Registration
Statement under the provisions of the Securities Act of 1933, as amended.


                                   Very truly yours,

                                   /s/ John M. Dab

                                   John M. Dab
                                   General Counsel



<PAGE>
                                                                   EXHIBIT 23.2

                  CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS




To American Technologies Group, Inc.:

As independent public accountants, we hereby consent to the incorporation by 
reference in this Form S-3 registration statement of our report dated 
November 10, 1998 included in the Company's Form 10-KSB for the year ended 
July 31, 1998 and to all references to our Firm included in this registration 
statement.

                                       /s/ ARTHUR ANDERSEN LLP
                                       -----------------------
                                       ARTHUR ANDERSEN LLP

Los Angeles, California
March 3, 1999



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission